Experimental, three-drug chemotherapy regimen didn’t improve survival rates for patients, but treatment might still prove helpful for a small subset of patients.

With antibiotic resistance on the rise, Michael D.L. Johnson, PhD, is on a mission to discover new ways to neutralize harmful microorganisms.

An international research team co-led by Sarver Heart Center Director Hesham Sadek, MD, PhD, shows that about 25% of patients with artificial hearts can regenerate heart muscle after a heart attack.

Ginny L. Clements and Tom Rogers have each committed gifts of $1 million to the Sarver Heart Center to create a new cardiovascular research institute.

Parkinson’s disease causes difficulty in movement and balance, but its cognitive symptoms receive less attention and have no good treatments. A College of Medicine – Tucson team hopes to change that.

Rob Jackson, PhD, a postdoctoral researcher in the Department of Immunobiology, secured a pivotal National Institutes of Health grant to establish his career in virology and oral cancer.

Researchers in the Department of Psychiatry will use a $3M grant from the Department of Defense to examine a noninvasive, drug-free treatment for sleep disorders.

College of Medicine – Tucson researchers are leading a team that will test noncompression CT technology, which has the potential to detect more breast cancers while increasing comfort and decreasing radiation exposure.

Dr. Dedrick Jordan, formerly of Louisiana State University, will take the helm of the College of Medicine – Tucson Department of Neurology on Nov. 5.

Department of Pediatrics researchers are working to enhance prevention and treatment options for autoimmune diseases, which can be hard to diagnose and treat.